Obsessive–compulsive disorder

North Springs Psychiatry Hosts Open House to Debut Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

Retrieved on: 
Tuesday, August 27, 2019
Psychiatry, Neuroscience, Branches of biology, Neurotechnology, Neurophysiology, Neuropsychology, Treatment of depression, RTT, Transcranial magnetic stimulation, Brainsway, Obsessive–compulsive disorder, Major depressive disorder

The event will feature a chance for the public to meet the staff at North Springs Psychiatry and receive a demonstration of BrainsWay s Deep Transcranial Magnetic Stimulation (Deep TMS) for the treatment of Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD).

Key Points: 
  • The event will feature a chance for the public to meet the staff at North Springs Psychiatry and receive a demonstration of BrainsWay s Deep Transcranial Magnetic Stimulation (Deep TMS) for the treatment of Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD).
  • We aim to provide a comfortable, caring and personalized approach to psychiatry, said Amanda Batterbee, owner and psychiatric-mental health nurse practitioner PMHNP-BC at North Springs Psychiatry.
  • North Springs Psychiatry provides Deep TMS treatment, therapy services, psychiatric and diagnostic evaluation, genetic testing and more.
  • The open house will take place on Thursday, Sept. 12 from 6 p.m. to 8 p.m. at North Springs Psychiatry, 7660 Goddard St., #130, Colorado Springs, Colo. 80920.

IV Ketamine Infusions Dramatically Improve the Quality of Life for Severe Migraine Patient

Retrieved on: 
Friday, August 16, 2019
Psychoactive drugs, Drugs, Neurochemistry, RTT, Psychiatric diagnosis, General anesthetics, NMDA receptor antagonists, Amines, Ketamine, Treatment-resistant depression, Obsessive–compulsive disorder, Posttraumatic stress disorder

New treatment options such as IV ketamine are helping refractory patients get relief.

Key Points: 
  • New treatment options such as IV ketamine are helping refractory patients get relief.
  • After 42 years suffering from severe migraines, Diana Solverson had no quality of life.
  • "We use IV Ketamine Infusions for chronic pain as well as treatment-resistant depression, PTSD, OCD, anxiety and many more."
  • For more information regarding IV Ketamine Infusions, please visit ivketamine.com or call 727-KETAMINE (727-538-2646).

New York Psychiatrist, Dr. Aleksandra Krunic, Introduces Groundbreaking FDA-Cleared Helmet to Treat Obsessive-Compulsive Disorder (OCD)

Retrieved on: 
Wednesday, August 7, 2019
RTT, Psychiatric diagnosis, Psychiatry, Human behavior, Abnormal psychology, Anxiety, Magical thinking, Obsessive–compulsive disorder, Ritual, Major depressive disorder

Dr. Krunic has successfully treated patients for several years using BrainsWays helmet for depression that targets a different brain region.

Key Points: 
  • Dr. Krunic has successfully treated patients for several years using BrainsWays helmet for depression that targets a different brain region.
  • This treatment option could not come at a more crucial time, as OCD continues to remain difficult to treat.
  • The treatment administers magnetic waves through a cushioned helmet to specific, targeted parts in the deep structures of the brain.
  • Dr. Aleksandra Krunic specializes in comprehensive, individualized mental health care for children, adolescents, and adults living in New York City, Long Island and broader New York State.

NuMe TMS Clinics Now Offer FDA-Cleared Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Houston

Retrieved on: 
Tuesday, August 6, 2019
Psychiatry, Neuroscience, Branches of biology, Neurotechnology, Treatment of depression, Neurophysiology, Neuropsychology, Electrotherapy, Transcranial magnetic stimulation, Obsessive–compulsive disorder, Abraham Zangen

NuMe TMS recently announced the adoption of Deep TMS across their locations in Boise and Salt Lake City as well.

Key Points: 
  • NuMe TMS recently announced the adoption of Deep TMS across their locations in Boise and Salt Lake City as well.
  • NuMe TMS is the latest adopter of this technology and joins over 100 additional providers distributing Deep TMS services for OCD nationwide.
  • In the U.S., the Companys device has been FDA cleared for the treatment of major depressive disorder (MDD) since 2013 and is now FDA cleared (De-Novo) for the treatment of Obsessive-Compulsive Disorder (OCD).
  • The Company's systems have also received CE clearance and are sold worldwide for the treatment of various brain disorders.

Global Obsessive-Compulsive Disorder Drugs Market 2019-2023 | 5% CAGR Projection Over the Next Five Years | Technavio

Retrieved on: 
Friday, June 28, 2019
Biotechnology, Pharmaceutical, Health, Psychiatry, Human behavior, RTT, Psychiatric diagnosis, Abnormal psychology, Anxiety, Magical thinking, Obsessive–compulsive disorder, Ritual

The global obsessive-compulsive disorder drugs market is expected to post a CAGR of more than 5% during the period 2019-2023, according to the latest market research report by Technavio .

Key Points: 
  • The global obsessive-compulsive disorder drugs market is expected to post a CAGR of more than 5% during the period 2019-2023, according to the latest market research report by Technavio .
  • View the full release here: https://www.businesswire.com/news/home/20190628005248/en/
    Technavio has published a new market research report on the global obsessive-compulsive disorder drugs market from 2019-2023.
  • This global obsessive-compulsive disorder drugs market 2019-2023 research report also analyzes other significant trends and market drivers that will affect market growth over 2019-2023.
  • Global obsessive-compulsive disorder drugs market: Segmentation analysis
    This market research report segments the global obsessive-compulsive disorder drugs market by product (SSRI, TCA, and others), and geographic regions (North America, Europe, Asia, and ROW).

Discovery Institute: Are humans simply meat machines?

Retrieved on: 
Tuesday, June 11, 2019
Atheists, Articles, Philosophy, Psychiatric diagnosis, American atheists, Anxiety disorders, American psychologists, Anxiety, Obsessive–compulsive disorder, Compulsive behavior, Steven Pinker, Daniel Dennett

Humans are just machines made up of hundreds of thousands of tiny cellular robots.

Key Points: 
  • Humans are just machines made up of hundreds of thousands of tiny cellular robots.
  • About Science Uprising Episode 2 Mind: The Inescapable I
    The latest episode of Science Uprising challenges claims by materialists like Steven Pinker, Sam Harris, and Daniel Dennett that humans are simply robots without free will.
  • Jeff's breakthrough work in obsessive-compulsive disorder (OCD) provided the hard evidence that the mind can control the brain's chemistry.
  • Learn more about his research and writing on the brain and neuroplasticity at https://jeffreymschwartz.com/about/
    View original content to download multimedia: http://www.prnewswire.com/news-releases/discovery-institute-are-humans-s...

Obsessive-Compulsive Disorder Pipeline Review, H1 2019 Report Featuring Addex Therapeutics, Amorsa Therapeutics, Biohaven Pharmaceutical, & Omeros - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 23, 2019
Health, Mental health, Pharmaceutical, Psychiatry, Human behavior, Psychiatric diagnosis, Psychology, Anxiety, Magical thinking, Obsessive–compulsive disorder, RTT, Ritual, Disorder, Pipeline, Book:Journeyman

The Obsessive-Compulsive Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued projects.

Key Points: 
  • The Obsessive-Compulsive Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued projects.
  • The pipeline guide reviews pipeline therapeutics for Obsessive-Compulsive Disorder (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide reviews key companies involved in Obsessive-Compulsive Disorder (Central Nervous System) therapeutics and enlists all their major and minor projects.

Carolina Partners in Mental HealthCare Expands Treatment Offerings to Include Revolutionary Mental Health Technology for Obsessive-Compulsive Disorder in North Carolina

Retrieved on: 
Monday, May 13, 2019
Human behavior, Psychiatry, Articles, Disability, Mental health, Positive psychology, Social constructionism, Obsessive–compulsive disorder, Jonathan Abramowitz

"Carolina Partners is thrilled to be an early adopter of BrainsWay's new OCD device in North Carolina, and we are looking forward to helping our patients achieve positive outcomes with the treatment.

Key Points: 
  • "Carolina Partners is thrilled to be an early adopter of BrainsWay's new OCD device in North Carolina, and we are looking forward to helping our patients achieve positive outcomes with the treatment.
  • Carolina Partners is one of the largest privately owned behavioral and mental health practices in the country, with offices throughout the state of North Carolina.
  • With nearly 200,000 patient encounters in 2018, Carolina Partners in Mental HealthCare (CPMH) is the largest outpatient mental and behavioral healthcare services provider in North Carolina.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/carolina-partners-in-mental-heal...
    SOURCE Carolina Partners in Mental HealthCare, PLLC

Atema Partners Acquires OCD Labs

Retrieved on: 
Friday, March 29, 2019
Human behavior, Psychiatry, Psychiatric diagnosis, Anxiety, Magical thinking, Obsessive–compulsive disorder, RTT, Ritual, Psychology

FRANKLIN, Tenn., March 29, 2019 /PRNewswire/ -- Atema Partners, Inc. has acquired OCD Labs, the forerunner in custom wiring and infrastructure packaging for concert touring and fixed production.

Key Points: 
  • FRANKLIN, Tenn., March 29, 2019 /PRNewswire/ -- Atema Partners, Inc. has acquired OCD Labs, the forerunner in custom wiring and infrastructure packaging for concert touring and fixed production.
  • "We are excited to add the type of product and service offerings that OCD Labs provides," says Atema Partners founder and CEO Tom Atema Jr. "If you've been part of any live production anywhere in the country in the past couple of years, you've seen some of OCD Labs' best-in-class projects at work," he says.
  • "As a relationship company, we are looking forward to continuing the established relationships that OCD Labs has cultivated among so many valued clients."
  • About Atema Partners, Inc.: Atema Partners was founded in 2008 by Tom Atema Jr.

OfferUp Spring Cleaning Survey Finds One Third of Americans are Planning to Spend a Full Day or More Decluttering Their Homes

Retrieved on: 
Wednesday, March 13, 2019
Abnormal psychology, Compulsive decluttering, Obsessive–compulsive disorder

Online marketplaces like OfferUp help people more easily sell the things they don't need and find things they want at a better value.

Key Points: 
  • Online marketplaces like OfferUp help people more easily sell the things they don't need and find things they want at a better value.
  • "For years, Americans have filled every empty space in their homes with too many items they don't use.
  • "Decluttering makes people feel good and provides them the opportunity to make money by reselling to someone that'll make better use of their things."
  • This spring, 37 percent of Americans are planning to spend a full day or more decluttering; 24 percent are planning to spend one or two hours doing so.